HEART评分对急诊胸痛患者主要不良心脏事件预后的预测准确性:系统评价与Meta分析
该系统评价与Meta分析检索多个数据库至2018年5月,纳入30项研究共44,202例急诊胸痛成人患者,评估HEART评分预测短期(30天或6周)主要不良心脏事件的预后准确性。HEART评分≥4(低风险阈值以上)预测主要不良心脏事件的灵敏度为95.9%(95%CI 93.3%-97.5%),特异度为44.6%(95%CI 38.8%-50.5%);HEART评分≥7(高风险)灵敏度39.5%(95%CI 31.6%-48.1%),特异度95.0%(95%CI 92.6%-96.6%)。HEART评分≥4预测死亡的灵敏度为95.0%(95%CI 87.2%-98.2%),预测心肌梗死的灵敏度为97.5%(95%CI 93.7%-99.0%)。作者结论认为HEART评分对主要不良心脏事件(尤其是死亡和心肌梗死)预测性能优异,应作为该人群风险分层的主要临床决策工具。
要点
- HEART评分≥4预测短期主要不良心脏事件的灵敏度95.9%(95%CI 93.3%-97.5%),特异度44.6%(95%CI 38.8%-50.5%)。
- HEART评分≥7(高风险)预测主要不良心脏事件的灵敏度39.5%(95%CI 31.6%-48.1%),特异度95.0%(95%CI 92.6%-96.6%)。
- HEART评分≥4预测死亡的灵敏度95.0%(95%CI 87.2%-98.2%),预测心肌梗死的灵敏度97.5%(95%CI 93.7%-99.0%)。
- TIMI评分≥2预测主要不良心脏事件的灵敏度87.8%(95%CI 80.2%-92.8%),特异度48.1%(95%CI 38.9%-57.5%)。
- TIMI评分≥6预测主要不良心脏事件的灵敏度仅2.8%(95%CI 0.8%-9.6%),特异度99.6%(95%CI 98.5%-99.9%)。
适用人群与场景
- 急诊科就诊的成人胸痛患者,用于预测短期(30天或6周)主要不良心脏事件。
诊断标准与关键阈值
- HEART评分低风险阈值以上定义为≥4分,高风险定义为≥7分。
- TIMI评分低风险阈值以上定义为≥2分,高风险定义为≥6分。
研究设计与关键结果
- 系统评价与Meta分析,纳入30项研究共44,202例急诊胸痛成人患者,主要结局为短期(30天或6周)主要不良心脏事件发生率。
- HEART评分≥4预测主要不良心脏事件:灵敏度95.9%(95%CI 93.3%-97.5%),特异度44.6%(95%CI 38.8%-50.5%)。
- HEART评分≥7预测主要不良心脏事件:灵敏度39.5%(95%CI 31.6%-48.1%),特异度95.0%(95%CI 92.6%-96.6%)。
- TIMI评分≥2预测主要不良心脏事件:灵敏度87.8%(95%CI 80.2%-92.8%),特异度48.1%(95%CI 38.9%-57.5%)。
- TIMI评分≥6预测主要不良心脏事件:灵敏度2.8%(95%CI 0.8%-9.6%),特异度99.6%(95%CI 98.5%-99.9%)。
- HEART评分≥4预测死亡:灵敏度95.0%(95%CI 87.2%-98.2%);预测心肌梗死:灵敏度97.5%(95%CI 93.7%-99.0%)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入30项研究(n=44,202)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为HEART评分对急诊胸痛患者主要不良心脏事件(尤其是死亡和心肌梗死)预测性能优异,应作为该人群风险分层的主要临床决策工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The HEART score has been proposed for emergency department (ED) prediction of major adverse cardiac events (MACE). We sought to summarize all studies assessing the prognostic accuracy of the HEART score for prediction of MACE in adult ED patients presenting with chest pain.
METHODS: We searched MEDLINE, PubMed, EMBASE, Scopus, Web of Science, and the Cochrane Database of Systematic Reviews from inception through May 2018 and included studies using the HEART score for the prediction of short-term MACE in adult patients presenting to the ED with chest pain. The main outcome was short-term (i.e., 30-day or 6-week) incidence of MACE. We secondarily evaluated the prognostic accuracy of the HEART score for prediction of mortality and myocardial infarction (MI). Where available, accuracy of the Thrombolysis in Myocardial Infarction (TIMI) score was determined.
RESULTS: We included 30 studies (n = 44,202) in analysis. A HEART score above the low-risk threshold (≥4) had a sensitivity of 95.9% (95% confidence interval [CI] = 93.3%-97.5%) and specificity of 44.6% (95% CI = 38.8%-50.5%) for MACE. A high-risk HEART score (≥7) had a sensitivity of 39.5% (95% CI = 31.6%-48.1%) and specificity of 95.0% (95% CI = 92.6%-96.6%) for MACE, whereas a TIMI score above the low-risk threshold (≥2) had a sensitivity of 87.8% (95% CI = 80.2%-92.8%) and specificity of 48.1% (95% CI = 38.9%-57.5%) for MACE. A high-risk TIMI score (≥6) was 2.8% sensitive (95% CI = 0.8%-9.6%), but 99.6% (95% CI = 98.5%-99.9%) specific for MACE. A HEART score ≥ 4 had a sensitivity of 95.0% (95% CI = 87.2%-98.2%) for prediction of mortality and 97.5% (95% CI = 93.7%-99.0%) for prediction of MI.
CONCLUSIONS: The HEART score has excellent performance for prediction of MACE (particularly mortality and MI) in chest pain patients and should be the primary clinical decision instrument used for the risk stratification of this patient population.
参考来源
- Fernando SM, Tran A, Cheng W, et al. Prognostic Accuracy of the HEART Score for Prediction of Major Adverse Cardiac Events in Patients Presenting With Chest Pain: A Systematic Review and Meta-analysis. Acad Emerg Med. 2018. PMID: 30375097. doi:10.1111/acem.13649
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。